We are live on
!
Find out more
FRM
Fox Run Management Portfolio holdings
AUM
$572M
1-Year Est. Return
24.16%
This Fund
S&P 500
This Quarter
Est. Return
+0.14%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$150M
AUM Growth
+$20.3M
(+16%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
10.5%
Top 10 Holdings %
Top 10 Hldgs %
9.04%
Holding
664
New
292
Increased
44
Reduced
53
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$1.11M |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.11M |
| 3 |
Nike
NKE
|
+$1.03M |
| 4 |
PAY
Verifone Systems Inc
PAY
|
+$959K |
| 5 |
MON
Monsanto Co
MON
|
+$894K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.43M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.19M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.41M |
| 4 |
Enterprise Products Partners
EPD
|
+$1.02M |
| 5 |
Magna International
MGA
|
+$933K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.63% |
| 2 | Healthcare | 14.32% |
| 3 | Technology | 11.92% |
| 4 | Industrials | 11.68% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STOR
276
DELISTED
STORE Capital Corporation
STOR
| $256K | 0.17% |
+9,900
| New | +$243K |
|
277
PNC Financial Services
PNC
$100B
| $254K | 0.17% |
+3,000
| New | +$255K |
|
278
Ubiquiti
UI
$31.8B
| $253K | 0.17% |
+7,600
| New | +$236K |
|
|
DATA
279
DELISTED
Tableau Software, Inc.
DATA
| $252K | 0.17% |
+5,500
| New | +$319K |
|
280
Duke Energy
DUK
$102B
| $250K | 0.17% |
+3,100
| New | +$235K |
|
281
Mohawk Industries
MHK
$6.9B
| $248K | 0.17% |
+1,300
| New | +$226K |
|
282
Qorvo
QRVO
$7.63B
| $247K | 0.17% |
4,900
-300
| -6% | -$13.1K |
|
|
MYCC
283
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $247K | 0.17% |
+17,600
| New | +$232K |
|
|
SJR
284
DELISTED
Shaw Communications Inc.
SJR
| $245K | 0.16% |
+12,700
| New | +$222K |
|
|
CBPX
285
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $245K | 0.16% |
+13,200
| New | +$214K |
|
|
CPPL
286
DELISTED
Columbia Pipeline Partners LP
CPPL
| $244K | 0.16% |
+16,700
| New | +$256K |
|
|
ASRT
287
DELISTED
Assertio
ASRT
| $242K | 0.16% |
+290
| New | +$269K |
|
288
BJ's Restaurants
BJRI
$1.41B
| $241K | 0.16% |
5,800
-2,500
| -30% | -$107K |
|
289
Oracle
ORCL
$331B
| $241K | 0.16% |
5,900
-5,400
| -48% | -$200K |
|
|
RAI
290
DELISTED
Reynolds American Inc
RAI
| $241K | 0.16% |
4,800
-2,200
| -31% | -$108K |
|
291
Cameco
CCJ
$38.3B
| $240K | 0.16% |
18,700
+5,200
| +39% | +$62.2K |
|
|
OPLN
292
Openlane
OPLN
$4.17B
| $240K | 0.16% |
+16,645
| New | +$221K |
|
293
Molson Coors Class B
TAP
$7.68B
| $240K | 0.16% |
+2,500
| New | +$223K |
|
294
VF Corp
VFC
$6.68B
| $240K | 0.16% |
+3,929
| New | +$228K |
|
295
Xerox
XRX
$337M
| $238K | 0.16% |
+8,083
| New | +$208K |
|
296
Corpay
CPAY
$24.2B
| $238K | 0.16% |
+1,600
| New | +$208K |
|
297
Broadridge
BR
$17.2B
| $237K | 0.16% |
+4,000
| New | +$218K |
|
298
Pacific Biosciences
PACB
$422M
| $237K | 0.16% |
+27,900
| New | +$274K |
|
|
TEF
299
DELISTED
Telefonica
TEF
| $236K | 0.16% |
+27,286
| New | +$222K |
|
300
Black Hills Corp
BKH
$5.73B
| $235K | 0.16% |
+3,900
| New | +$208K |
|
Similar funds
MAM
NA
EHI
MW
BSG
RI
XI
TWA
Fox Run Management's Q1 2016 Portfolio in Review
As of Q1 2016, Fox Run Management held 664 positions worth $150M, up 16% from $129M the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Fox Run Management deployed $15.7M of net new capital in Q1 2016, opening 292 new positions and adding to 44 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.43M trimmed.
- Fox Run Management's largest Q1 2016 buy was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
- Fox Run Management added most to Hologic in Q1 2016, an estimated $823K increase.
- Fox Run Management's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.43M.
- Fox Run Management fully exited Enterprise Products Partners in Q1 2016, selling an estimated $1.02M.
- Fox Run Management's ten largest holdings make up 9% of its $150M portfolio in Q1 2016.
- Fox Run Management opened 292 new positions and closed 273 in Q1 2016.
- Fox Run Management's portfolio value rose 16% quarter-over-quarter to $150M.
Based on Fox Run Management's 13F filing for Q1 2016, filed 18 Apr 2016.